sb.scorecardresearch
Advertisement

Published 09:05 IST, September 9th 2020

Indian-origin professor’s UK firm strikes Covid-19 vaccine pact with India

An Indian-origin professor’s Oxford-based company on Tuesday announced that its Indian partner, the Serum Institute of India (SIIPL), has begun trials of a novel virus-like particle (VLP) vaccine targeting Covid-19 which has the potential to offer a groundbreaking new approach to fighting the pandemic.

Follow: Google News Icon
  • share
null | Image: self
Advertisement

09:05 IST, September 9th 2020